All Stories

  1. Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

    Article • OncoTargets and Therapy, January 2017, Dove Medical Press

    dr KASHIF ASGHAR, Mr Bilal Zulfiqar, Dr. Nasir NJ Jalal